Joseph Holthoff is a Nephrology physician affiliated with Central Arkansas Veterans Healthcare System. OpenAlex indexes 37 publications with 787 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 W Markham St # 501
Little Rock, AR 722057101
Telephone
501-686-1020Provider last certified this registry record 4 Aug 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20252 payments
- Travere Therapeutics, Inc.Program year20247 payments
- Quanta Dialysis Technologies IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.3%Angiotensin receptor blocker (ARB)21.2%Losartan Potassium100%Part D≥34 patientsLoop diuretic13.3%Bumetanide60%Furosemide40%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
25.3%Vitamin D3 Analog10.9%Calcitriol100%Part D≥14 patientsSGLT2 inhibitor8.8%Jardiance100%Part D<11 patients+ 2 more classes in this area
Nervous system
2.7%Gabapentinoids2.7%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2010–2014 per NIH RePORTER. The latest:
- Preclinical evaluation of resveratrol in sepsis-induced renal injury
Univ of Arkansas for Med Scis
FY2014$31,231F30DK085705 - Preclinical evaluation of resveratrol in sepsis-induced renal injury
Univ of Arkansas for Med Scis
FY2013$37,024F30DK085705 - Preclinical evaluation of resveratrol in sepsis-induced renal injury
Univ of Arkansas for Med Scis
FY2012$30,288F30DK085705
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy
Kidney International Reports
2025 - The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
American Journal of Physiology-Renal Physiology
2025 - The Second Slice Tells the Story: Evolving Cryoglobulinemia in Mesangial Glomerulonephritis
Journal of the American Society of Nephrology
2025 - Perfusion Under Pressure: Reversing Anuric AKI with Targeted Intra-Abdominal Pressure (IAP) Reduction
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Barry Uretsky, MD
Central Arkansas Veterans Healthcare System
Paulette Mehta, MD
Central Arkansas Veterans Healthcare System
Spyridoula Maraka, MD
Central Arkansas Veterans Healthcare System
Thaddeus Bartter, MD
Central Arkansas Veterans Healthcare System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”